Provepharm receives FDA marketing approval in US for BLUDIGO, its indigo carmine injection drug product
ABL and Coave Therapeutics enter into strategic collaboration to develop gene therapy manufacturing processes and create joint capabilities for process development of AAV-based gene therapy
BCI Pharma enters into strategic partnership with Mithra to identify novel therapy for endometriosis and cancer in women
BCI Pharma seeks to expand its library of kinase inhibitors and address innovative mechanisms of action for unmet medical needs
Contipharma launches saliva-based Omicron detecting PCR test in Africa
Developed by University of Liège in Belgium, only test of its kind available on African continent
First contracts signed with Democratic Republic of Congo, Burundi and Sudan
Limbach Group adopts QuantaMatrix dRAST™ in routine clinical use
QuantaMatrix’s direct Rapid Antimicrobial Susceptibility Testing system (dRAST) improves optimal prescription of antibiotics by two days compared to conventional methods
Following successful validation of dRAST platform in Europe at key reference laboratories, system now adopted for clinical use
Ferrer and CNIC unveil results of first real-world study of cnic-polypill showing decreased risk of major adverse cardiovascular events when compared to monocomponents administered separately
Deciphera obtient l’autorisation de la commission européenne pour le QINLOCK® (RIPRETINIB) en traitement de quatrième ligne des tumeurs stromales gastro-intestinales (GIST)
GTP Bioways invests € 12M in two GMP biopharmaceutical production units
GTP Bioways strengthens position as leading CDMO in Europe by opening two new biopharmaceutical production units at Toulouse site
GTP Bioways will become the unique CDMO in France with this offer, based on two new lines, one focused on microbial production, the other on small-scale mammalian-based production
L’Afssi dresse l’état des lieux des services de r&d dans les sciences de la vie en France lors des 8e Afssi connexions
Avec la crise sanitaire, les sociétés françaises de services et d’innovation en sciences de la vie ont pu montrer leur capacité d’adaptation, leur agilité et leur réactivité pour faire avancer la recherche en santé
L’édition 2021 des AFSSI Connexions, les 28 et 29 septembre, est l’occasion de mettre en avant le poids de la filière dans les enjeux de compétitivité et de souveraineté nationale en recherche dans la santé